Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Esophageal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Testing effectiveness (Phase 2)UnknownNCT02544737
What this trial is testing

Apatinib for Metastatic Esophageal Cancer.

Who this might be right for
Esophageal CancerMetastatic Esophageal CancerApatinib
Hangzhou Cancer Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00917462
What this trial is testing

Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer

Who this might be right for
Esophageal CancerGastroesophageal Junction Cancer
Memorial Sloan Kettering Cancer Center 35
Large-scale testing (Phase 3)UnknownNCT02448979
What this trial is testing

Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach

Who this might be right for
Esophageal Cancer
Chinese Academy of Medical Sciences 800
Not applicableStudy completedNCT03461341
What this trial is testing

European iNvestigation of SUrveillance After Resection for Esophageal Cancer

Who this might be right for
Esophageal CancerMetastatic CancerRecurrent Esophageal Cancer+4 more
St. James's Hospital, Ireland 3,000
Large-scale testing (Phase 3)Looking for participantsNCT06022861
What this trial is testing

Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shandong Boan Biotechnology Co., Ltd 510
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07533305
What this trial is testing

Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
QL1706ESCCFirst-line Therapy
The First Affiliated Hospital of Henan University of Science and Technology 50
Testing effectiveness (Phase 2)Looking for participantsNCT07367516
What this trial is testing

Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 105
Testing effectiveness (Phase 2)Study completedNCT00130689
What this trial is testing

Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer

Who this might be right for
Esophageal CancerGastric CancerNeoplasm Metastasis
Dana-Farber Cancer Institute 43
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Testing effectiveness (Phase 2)Ended earlyNCT04508140
What this trial is testing

Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis

Who this might be right for
Colorectal CancerGastric CancerOesophageal Cancer
Highlight Therapeutics 18
Testing effectiveness (Phase 2)Study completedNCT00719550
What this trial is testing

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

Who this might be right for
Esophagogastric Junction AdenocarcinomaGastric CancerEsophageal Cancer
Amgen 130
Testing effectiveness (Phase 2)UnknownNCT02545751
What this trial is testing

SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer

Who this might be right for
Esophageal CancerMetastatic Esophageal CancerStereotactic Body Radiation Therapy+1 more
Hangzhou Cancer Hospital 29
Testing effectiveness (Phase 2)UnknownNCT00453323
What this trial is testing

Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer

Who this might be right for
Esophageal Cancer
National Cancer Center, Korea 33
Large-scale testing (Phase 3)UnknownNCT01034683
What this trial is testing

Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma

Who this might be right for
Esophageal Carcinoma
Taian Cancer Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT03320629
What this trial is testing

Apatinib Plus Radiotherapy and S-1 for Treatment of Refractory or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Refractory or Metastatic Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 7
Testing effectiveness (Phase 2)Study completedNCT02406170
What this trial is testing

Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsNeoplasm Metastasis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 47
Not applicableStudy completedNCT01624220
What this trial is testing

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Who this might be right for
Spinal Tumor
M.D. Anderson Cancer Center 41
Large-scale testing (Phase 3)Active Not RecruitingNCT03504397
What this trial is testing

Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07290010
What this trial is testing

The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Hebei Medical University Fourth Hospital 25
Next Page
565